NewAmsterdam Pharma Company N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

21.84

+1.68 (8.33%)

At close: Jun 10, 2025, 4:00 PM

22.26

+0.42 (1.92%)

After-hours: Jun 10, 2025, 7:56 PM EDT

NAMS Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	47.14	45.56	14.09	102.69	-	-
Revenue Growth (YoY)	586.97%	223.37%	-86.28%	-	-	-
Gross Profit	47.14	45.56	14.09	102.69	-	-
Selling, General & Admin	83.15	70.45	37.63	19.51	6	1.69
Research & Development	153.73	151.41	159.42	86.74	28.97	4.95
Operating Expenses	236.87	221.85	197.06	106.25	34.98	6.64
Operating Income	-189.73	-176.29	-182.97	-3.56	-34.98	-6.64
Interest Expense	-	-	-	-0.29	-0.41	-0.42
Interest & Investment Income	21.15	16.88	11.28	-	-	-
Currency Exchange Gain (Loss)	0.11	-6.6	5.06	-9.75	1.71	0.03
Other Non Operating Income (Expenses)	5.43	-38.58	-10.02	-8.34	-7.22	-
EBT Excluding Unusual Items	-163.04	-204.59	-176.64	-21.93	-40.9	-7.03
Other Unusual Items	-24.32	-37.01	-0.27	-0.71	-0.88	-
Pretax Income	-187.36	-241.6	-176.91	-22.63	-41.79	-7.03
Income Tax Expense	-0	-0	0.03	-	-	-
Net Income	-187.36	-241.6	-176.94	-22.63	-41.79	-7.03
Net Income to Common	-187.36	-241.6	-176.94	-22.63	-41.79	-7.03
Shares Outstanding (Basic)	101	94	82	19	11	5
Shares Outstanding (Diluted)	101	94	82	19	11	5
Shares Change (YoY)	20.81%	14.84%	333.20%	72.75%	119.58%	-
EPS (Basic)	-1.85	-2.56	-2.15	-1.19	-3.81	-1.41
EPS (Diluted)	-1.85	-2.56	-2.15	-1.19	-3.81	-1.41
Free Cash Flow	-140.73	-159.24	-141.24	10.44	-29.54	-7.32
Free Cash Flow Per Share	-1.39	-1.69	-1.72	0.55	-2.69	-1.46
Gross Margin	100.00%	100.00%	100.00%	100.00%	-	-
Operating Margin	-402.49%	-386.91%	-1298.56%	-3.46%	-	-
Profit Margin	-397.45%	-530.25%	-1255.76%	-22.04%	-	-
Free Cash Flow Margin	-298.54%	-349.49%	-1002.43%	10.17%	-	-
EBITDA	-189.58	-176.18	-182.92	-3.55	-34.97	-6.64
EBITDA Margin	-	-	-	-3.45%	-	-
D&A For EBITDA	0.15	0.11	0.05	0.01	0.01	0
EBIT	-189.73	-176.29	-182.97	-3.56	-34.98	-6.64
EBIT Margin	-	-	-	-3.46%	-	-

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q